This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch
by Aparajita Dutta
UNH's post-earnings pullback follows a 52-week high, as stronger guidance offsets Medicaid pressures and spotlights healthcare ETFs with sizable exposure.
ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook
by Aparajita Dutta
Johnson & Johnson's Q2 beat and strong pharma momentum are raising interest in healthcare ETFs with sizable exposure to the company.
Are the Odds of a Wider Middle East Conflict Rising? ETFs to Consider
by Yashwardhan Jain
Nine consecutive days of U.S. airstrikes and ongoing retaliatory attacks have heightened fears of a broader Middle East conflict. Here are some ETFs that could benefit.
Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
by Aparajita Dutta
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.
How to Play Fresh U.S.-Iran Tensions With ETFs?
by Sanghamitra Saha
Market jitters return on fresh U.S.-Iran tensions. Energy, dividend, low-volatility and defensive ETFs could help investors navigate renewed uncertainty.
Should You Invest in the Vanguard Health Care Index Fund ETF Shares (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
by Aparajita Dutta
Healthcare ETFs are gaining attention as Middle East tensions and market volatility boost demand for defensive sectors.
Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet
by Aparajita Dutta
LLY's $4B vaccine push is boosting interest in healthcare ETFs like IHE with heavy exposure to the drugmaker.
US-Iran Ceasefire Hopes Fade: ETF Strategies to Play
by Sanghamitra Saha
U.S.-Iran tensions rise as Hormuz risks grow. Markets turn volatile -- dividend, low-beta, and defensive ETFs may help cushion portfolios.
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
by Aparajita Dutta
Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.